MétaCan
Menu
Back to cohort
Record W4414740949 · doi:10.1093/clinchem/hvaf086.487

B-089 Establishing an in-house quality control program for nine autoantibody assays using donor sera

2025· article· en· W4414740949 on OpenAlexaff
Mary Kathryn Bohn, Lusia Sepiashvili

Bibliographic record

VenueClinical Chemistry · 2025
Typearticle
Languageen
FieldMedicine
TopicMonoclonal and Polyclonal Antibodies Research
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsAutoantibodyTiterAntibodyCoefficient of variationAntibody titerImmunoglobulin G

Abstract

fetched live from OpenAlex

Abstract Background Evaluation of autoantibodies in patient sera is essential to inform clinical decision-making in the classification and management of autoimmune disease. Clinical laboratories performing semi-quantitative autoantibody testing face significant challenges in developing evidence-based quality management systems to assure performance. Careful consideration is required to evaluate assay imprecision, including quality control (QC) matrix, autoantibody titer targets, and performance goals. The objective of this study was to evaluate the performance of a novel patient-based QC solution relative to vendor-provided QC for nine autoantibodies over a four-year period at a tertiary pediatric care centre. Methods Internal QC data were extracted over a 4-year period for nine autoantibodies measured via chemiluminescent immunoassays (anti-double stranded DNA (dsDNA), anti-ribonuclear protein, anti-Ro52, anti-Ro60, anti-La, anti-Smith, anti-proteinase 3, anti-myeloperoxidase, and anti-tissue transglutaminase IgA). QC evaluated during study period included vendor-based QC and third-party patient-based QC. For patient-based QC, autoantibody-positive specimens (defibrinated plasma from single human donors) were acquired by our laboratory for in-house evaluation. Following pre-testing, one individual donor specimen was selected and diluted to the desired titer using pooled immunoglobulin depleted sera and stored at -80°C until testing. Lot-specific QC coefficients of variation (CV), titer means, and standard deviations were calculated and compared across QC matrices. Results Approximately 500 QC values per autoantibody were evaluated. Mean CV across lots ranged from 8.2 to 14.4% for negative vendor-based QC, 8.2-14.5% for positive vendor-based QC, and 9.8-17.8% for positive patient-based QC across evaluated autoantibodies. Anti-dsDNA and anti-Ro52 (demonstrated a statistically significant (p-value<0.001) difference between calculated CVs for vendor-based QC (anti-dsDNA: 8.2%, anti-Ro52: 9.8%) relative to patient-based QC (anti-dsDNA: 17.8%, anti-Ro52: 15.1%). Imprecision estimates for the other autoantibodies evaluated did not demonstrate significant differences between matrices. Conclusion This study evaluates the performance of a third-party patient-based QC solution relative to vendor-based QC using real-time clinical laboratory data for nine autoantibodies measured using chemiluminescent immunoassays. These data contribute to the limited literature on practical considerations for autoantibody QC and may serve as a benchmark tool to assess autoantibody imprecision across different matrices. Based on our findings, clinical laboratories may consider supplementing vendor-based QC with single patient donor QC materials, where available, to provide an independent performance assessment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.375
Threshold uncertainty score0.790

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.118
GPT teacher head0.525
Teacher spread0.407 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueClinical ChemistrySame topicMonoclonal and Polyclonal Antibodies ResearchFrench-language works237,207